Tyrosine Hydroxylase
Tyrosine Hydroxylase - Related Videos
01:26
Receptor Tyrosine Kinases
0 Views •
2025
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
0 Views •
Cited by 6 •
2013
Receptor tyrosine kinases are ectopically expressed in many cancers and have been identified as therapeutic targets in acute leukemia. This manuscript describes an efficient strategy for pre-clinical evaluation of tyrosine kinase inhibitors for the treatment of acute leukemia.
06:56
Development and Application of Rapamycin-regulated Tyrosine Phosphatases
0 Views •
2024
This protocol describes the design, creation, and application of rapamycin-regulated phosphatases. This method provides high specificity and tight temporal control of phosphatase activation in living cells.
07:42
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
0 Views •
Cited by 1 •
2018
Here, we present a protocol for antibody arrays to identify alterations in signaling pathways in various cellular models. These changes, caused by drugs/hypoxia/ultra-violet light/radiation, or by overexpression/downregulation/knockouts, are important for various disease models and can indicate whether a therapy will be effective or can identify mechanisms of drugs resistance.
01:26
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
0 Views •
2024
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath. TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
FAQs
Its rate-limiting position makes Tyrosine Hydroxylase a potential control point for catecholamine pathway output. Changes in its activity can affect how efficiently L-tyrosine is directed toward L-DOPA, the precursor formed at this step. Consequently, bioengineers can examine this enzyme when optimizing systems intended to produce dopamine, norepinephrine, or epinephrine.
The hydroxylation reaction depends on oxygen, tetrahydrobiopterin, and a catalytic iron center working within the enzyme system. Oxygen supports the reaction, tetrahydrobiopterin serves as the required cofactor, and iron forms part of the catalytic center. Their inclusion is therefore essential when interpreting enzyme activity or designing an engineered production system.
Regulation provides an additional control layer beyond the enzyme’s catalytic requirements. Examining how Tyrosine Hydroxylase activity is regulated can help identify opportunities to adjust catecholamine pathway performance rather than focusing only on substrate or cofactor availability. In bioengineering, this makes regulation a relevant target for optimizing systems that produce catecholamines or related compounds.
These catecholamines are connected through their shared biosynthetic entry point at the Tyrosine Hydroxylase reaction. By converting L-tyrosine to L-DOPA, the enzyme initiates the pathway that supports study and engineering of dopamine, norepinephrine, and epinephrine production. Its position therefore links one enzymatic step to several downstream production objectives.
In a microbial or cell-based production system, researchers can evaluate Tyrosine Hydroxylase as a key component of an engineered catecholamine pathway. The design must account for its substrate, oxygen-dependent reaction, tetrahydrobiopterin cofactor, and iron center. Considering these requirements helps relate enzyme activity to the system’s capacity to generate L-DOPA and related catecholamines.
Tyrosine Hydroxylase is relevant because altered activity at this early, rate-limiting point can provide a way to investigate problems involving neurotransmitter synthesis. Studying its activity, regulation, and cofactor requirements helps connect molecular enzyme function with catecholamine production. This context supports research into disorders involving the synthesis of dopamine, norepinephrine, or epinephrine.